These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30530705)

  • 1. The Senescence-associated Secretory Phenotype Mediates Oncogene-induced Senescence in Pediatric Pilocytic Astrocytoma.
    Buhl JL; Selt F; Hielscher T; Guiho R; Ecker J; Sahm F; Ridinger J; Riehl D; Usta D; Ismer B; Sommerkamp AC; Martinez-Barbera JP; Wefers AK; Remke M; Picard D; Pusch S; Gronych J; Oehme I; van Tilburg CM; Kool M; Kuhn D; Capper D; von Deimling A; Schuhmann MU; Herold-Mende C; Korshunov A; Brummer T; Pfister SM; Jones DTW; Witt O; Milde T
    Clin Cancer Res; 2019 Mar; 25(6):1851-1866. PubMed ID: 30530705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing.
    Selt F; Hohloch J; Hielscher T; Sahm F; Capper D; Korshunov A; Usta D; Brabetz S; Ridinger J; Ecker J; Oehme I; Gronych J; Marquardt V; Pauck D; Bächli H; Stiles CD; von Deimling A; Remke M; Schuhmann MU; Pfister SM; Brummer T; Jones DT; Witt O; Milde T
    Oncotarget; 2017 Feb; 8(7):11460-11479. PubMed ID: 28002790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRAF activation induces transformation and then senescence in human neural stem cells: a pilocytic astrocytoma model.
    Raabe EH; Lim KS; Kim JM; Meeker A; Mao XG; Nikkhah G; Maciaczyk J; Kahlert U; Jain D; Bar E; Cohen KJ; Eberhart CG
    Clin Cancer Res; 2011 Jun; 17(11):3590-9. PubMed ID: 21636552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic aberrations leading to MAPK pathway activation mediate oncogene-induced senescence in sporadic pilocytic astrocytomas.
    Jacob K; Quang-Khuong DA; Jones DT; Witt H; Lambert S; Albrecht S; Witt O; Vezina C; Shirinian M; Faury D; Garami M; Hauser P; Klekner A; Bognar L; Farmer JP; Montes JL; Atkinson J; Hawkins C; Korshunov A; Collins VP; Pfister SM; Tabori U; Jabado N
    Clin Cancer Res; 2011 Jul; 17(14):4650-60. PubMed ID: 21610151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of pediatric brain tumors identifies microRNAs in pilocytic astrocytomas that target the MAPK and NF-κB pathways.
    Jones TA; Jeyapalan JN; Forshew T; Tatevossian RG; Lawson AR; Patel SN; Doctor GT; Mumin MA; Picker SR; Phipps KP; Michalski A; Jacques TS; Sheer D
    Acta Neuropathol Commun; 2015 Dec; 3():86. PubMed ID: 26682910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BH3 mimetics targeting BCL-XL impact the senescent compartment of pilocytic astrocytoma.
    Selt F; Sigaud R; Valinciute G; Sievers P; Zaman J; Alcon C; Schmid S; Peterziel H; Tsai JW; Guiho R; Martínez-Barbera JP; Pusch S; Deng J; Zhai Y; van Tilburg CM; Schuhman MU; El Damaty A; Bandopadhayay P; Herold-Mende C; von Deimling A; Pfister SM; Montero J; Capper D; Oehme I; Sahm F; Jones DTW; Witt O; Milde T
    Neuro Oncol; 2023 Apr; 25(4):735-747. PubMed ID: 35977048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of patient-derived pediatric pilocytic astrocytoma in-vitro models using SV40 large T: evaluation of a modeling workflow.
    Selt F; El Damaty A; Schuhmann MU; Sigaud R; Ecker J; Sievers P; Kocher D; Herold-Mende C; Oehme I; von Deimling A; Pfister SM; Sahm F; Jones DTW; Witt O; Milde T
    J Neurooncol; 2023 Dec; 165(3):467-478. PubMed ID: 37999877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inorganic arsenic exposure-induced premature senescence and senescence-associated secretory phenotype (SASP) in human hepatic stellate cells.
    Okamura K; Sato M; Suzuki T; Nohara K
    Toxicol Appl Pharmacol; 2022 Nov; 454():116231. PubMed ID: 36089002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Surgical and Radiologic Risk Factors for Progression or Recurrence of Pediatric Pilocytic Astrocytoma.
    Villanueva KG; Rea ND; Krieger MD
    Pediatr Neurosurg; 2019; 54(6):375-385. PubMed ID: 31593969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of p16 alleviates the senescence-associated secretory phenotype.
    Buj R; Leon KE; Anguelov MA; Aird KM
    Aging (Albany NY); 2021 Feb; 13(3):3290-3312. PubMed ID: 33550279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The histomolecular criteria established for adult anaplastic pilocytic astrocytoma are not applicable to the pediatric population.
    Gareton A; Tauziède-Espariat A; Dangouloff-Ros V; Roux A; Saffroy R; Castel D; Kergrohen T; Fina F; Figarella-Branger D; Pagès M; Bourdeaut F; Doz F; Puget S; Dufour C; Lechapt E; Chrétien F; Grill J; Varlet P
    Acta Neuropathol; 2020 Feb; 139(2):287-303. PubMed ID: 31677015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence patterns and anaplastic change in a long-term study of pilocytic astrocytomas.
    Krieger MD; Gonzalez-Gomez I; Levy ML; McComb JG
    Pediatr Neurosurg; 1997 Jul; 27(1):1-11. PubMed ID: 9486830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A complex secretory program orchestrated by the inflammasome controls paracrine senescence.
    Acosta JC; Banito A; Wuestefeld T; Georgilis A; Janich P; Morton JP; Athineos D; Kang TW; Lasitschka F; Andrulis M; Pascual G; Morris KJ; Khan S; Jin H; Dharmalingam G; Snijders AP; Carroll T; Capper D; Pritchard C; Inman GJ; Longerich T; Sansom OJ; Benitah SA; Zender L; Gil J
    Nat Cell Biol; 2013 Aug; 15(8):978-90. PubMed ID: 23770676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MLL1 is essential for the senescence-associated secretory phenotype.
    Capell BC; Drake AM; Zhu J; Shah PP; Dou Z; Dorsey J; Simola DF; Donahue G; Sammons M; Rai TS; Natale C; Ridky TW; Adams PD; Berger SL
    Genes Dev; 2016 Feb; 30(3):321-36. PubMed ID: 26833731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metronomic topotecan impedes tumor growth of MYCN-amplified neuroblastoma cells in vitro and in vivo by therapy induced senescence.
    Taschner-Mandl S; Schwarz M; Blaha J; Kauer M; Kromp F; Frank N; Rifatbegovic F; Weiss T; Ladenstein R; Hohenegger M; Ambros IM; Ambros PF
    Oncotarget; 2016 Jan; 7(3):3571-86. PubMed ID: 26657295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral pilocytic astrocytoma.
    Clark GB; Henry JM; McKeever PE
    Cancer; 1985 Sep; 56(5):1128-33. PubMed ID: 4016701
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Zhang JW; Zhang D; Yin HS; Zhang H; Hong KQ; Yuan JP; Yu BP
    Gut Microbes; 2023; 15(1):2197836. PubMed ID: 37017266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic and scalable assessment of the senescence-associated secretory phenotype (SASP).
    Malaquin N; Rodier F
    Methods Cell Biol; 2024; 181():181-195. PubMed ID: 38302239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for new targets and synergistic effect of metronomic celecoxib/fluvastatin combination in pilocytic astrocytoma.
    Mercurio S; Padovani L; Colin C; Carré M; Tchoghandjian A; Scavarda D; Lambert S; Baeza-Kallee N; Fernandez C; Chappé C; André N; Figarella-Branger D
    Acta Neuropathol Commun; 2013 May; 1():17. PubMed ID: 24252689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protein kinase D1-mediated classical protein secretory pathway regulates the Ras oncogene-induced senescence response.
    Su Y; Wang P; Shen H; Sun Z; Xu C; Li G; Tong T; Chen J
    J Cell Sci; 2018 Mar; 131(6):. PubMed ID: 29420297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.